publishes bioterror paper, after delay

Courtesy of Scott Bauer, ARSFour weeks after delaying publication of a paper at the request of the US Department of Health and Human Services (HHS), the Proceedings of the National Academy of Sciences (PNAS) published the paper in late June.1 The study pinpoints areas in the dairy industry that are vulnerable to bioterror attacks.In the paper, professor of management science Lawrence M. Wein and graduate student Yifan Liu of Stanford University explain how bioterrorists could poison the US milk

Written byAlison McCook
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Courtesy of Scott Bauer, ARS

Four weeks after delaying publication of a paper at the request of the US Department of Health and Human Services (HHS), the Proceedings of the National Academy of Sciences (PNAS) published the paper in late June.1 The study pinpoints areas in the dairy industry that are vulnerable to bioterror attacks.

In the paper, professor of management science Lawrence M. Wein and graduate student Yifan Liu of Stanford University explain how bioterrorists could poison the US milk supply with trace amounts of botulinum toxin. The authors detail the amount needed to kill hundreds of thousands of people, the manner in which the toxin could sneak into the milk supply, and the interventions that could head off such an attack.

In an accompanying editorial, Bruce Alberts, president of the National Academy of Sciences, notes that PNAS decided to publish the article ''as originally accepted,'' because they believed ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies